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We describe the use of a unique DNA-modification-
dependent restriction endonuclease AbaSI coupled
with sequencing (Aba-seq) to map high-resolution
hydroxymethylome of mouse E14 embryonic stem
cells. The specificity of AbaSI enables sensitive
detection of 5-hydroxymethylcytosine (5hmC) at
low-occupancy regions. Bioinformatic analysis
suggests 5hmCs in genic regions closely follow the
5mC distribution. 5hmC is generally depleted in
CpG islands and only enriched in a small set of repet-
itive elements. A regularly spaced and oscillating
5hmC pattern was observed at the binding sites of
CTCF. 5hmC is enriched at the poised enhancers
with the monomethylated histone H3 lysine 4
(H3K4me1) marks, but not at the active enhancers
with the acetylated histone H3 lysine 27 (H3K27Ac)
marks. Non-CG hydroxymethylation appears to be
prevalent in the mitochondrial genome. We propose
that some amounts of transiently stable 5hmCs
may indicate a poised epigenetic state or demethyla-
tion intermediate, whereas others may suggest
a locally accessible chromosomal environment for
the TET enzymatic apparatus.INTRODUCTION
The dynamic epigenomic landscape of the mammalian cell,
including chromatin states and DNA modifications, is set forth
by past cellular events, and it affects the developmental trajec-
tory of the cell by regulating the genome-wide expression. DNA
modifications such as 5-methylcytosine (5mC) are laid onto the
genome by various DNA methyltransferases (e.g., DNMT1,
DNMT3A, and DNMT3B) and undergo cycles of erasure and
re-establishment at both genomic and regional levels. The
unique methylomes are largely maintained in differentiated cell
types, making them a key feature in understanding the differen-Ctiation potential of the cell. Recently, it was shown that 5-hy-
droxymethylcytosine (5hmC) is an oxidation product of the
TET1/2/3 and is enriched in neuronal tissues as well as in
embryonic stem cells (ESCs) (Kriaucionis and Heintz, 2009; Ta-
hiliani et al., 2009). Successive oxidation of 5hmC by the TET
enzymes produces 5-formylcytosine (5fC) and 5-carboxycyto-
sine (5caC), which are found at a lower abundance in the
genome (He et al., 2011; Ito et al., 2011). It was then realized
that conventional cytosine methylation profiling methods,
including bisulfite sequencing, cannot distinguish between
5mC and 5hmC (Huang et al., 2010; Jin et al., 2010). Hence,
dissection of the hydroxymethylome from the methylome has
become a priority in understanding its role in the genome regu-
lation circuitry.
A number of methods have been developed to investigate the
genome-wide distribution of 5hmC and its dynamics. For
example, based on the differential sensitivity of MspI and HpaII
to modified cytosines, 5hmC/5mC/C levels can be quantitatively
estimated at any CCGG sites (Kinney et al., 2011). Several
genome-wide studies have used 5hmC-specific antibodies
(hMeDIP) or chemical affinity tags to enrich 5hmC-containing
DNA for sequencing (Song et al., 2011; Ficz et al., 2011; Pastor
et al., 2011; Williams et al., 2011; Wu et al., 2011). Although
limited by resolution, these studies yielded many insightful
observations. Recently, twomethods of base-resolution hydrox-
ymethylomemappingwere reported (Booth et al., 2012; Yu et al.,
2012). Both methods utilized the differential readout of various
modified cytosines after bisulfite conversion and sequencing.
5mC and 5hmC are read as cytosine after bisulfite sequencing,
whereas further oxidized products of 5hmCs (5fC or 5caC) are
read as thymine. One method (oxoBS-seq) achieved the selec-
tive chemical oxidation of 5hmC to 5fC by using potassium
perruthenate (KRuO4) (Booth et al., 2012). The other method
(Tet-assisted bisulfite sequencing, TAB-seq) first blocked the
existing 5hmC by glucosylation and then converted all genomic
5mC to 5caC by utilizing the in vitro enzymatic oxidation of TET1
(Yu et al., 2012). Both methods used traditional bisulfite conver-
sion and sequencing to decipher methylome and hydroxymethy-
lome. However, several technical hurdles may still persist. For
example, DNA complexity and integrity are further compromised
after the treatment which may hamper the amplification stepsell Reports 3, 567–576, February 21, 2013 ª2013 The Authors 567
Figure 1. Overview of Aba-seq and Validation of the Identified 5hmC Sites
(A) Recognition and cleavage sites of AbaSI.
(B) Schematic overview of the Aba-seq method. 1: glucosylated genomic DNA was digested with AbaSI. 2: digested DNA was ligated to a biotinylated adaptor
P1bwith 2-base 30-overhang. 3: DNA fragmentation by sonication. 4: capture of the biotinylated DNA onto avidin-coated beads. 5 and 6: on-beadDNA end-repair
and dA-tailing. 7: on-bead ligation with adaptor P2 containing one blunt end and one unligatable end. 8: PCR using primers specific to the P1b and P2.
(C) Distribution of different categories of identified AbaSI cleavage sites.
(D) Representative sequence logos of the largest categories 1CG1CH.
See also Figure S1 and Table S1.and the subsequent read mapping. In addition, sequencing
depth for each cytosine must be considerably high to detect
low-level 5hmCs (Yu et al., 2012).
Alternative methods, ideally with a facile application format,
are needed to complement the existing approaches. In previous
work we characterized a family of 5hmC-dependent restriction
endonucleases (Wang et al., 2011). One member in the family,
AbaSI, recognizes 5-glucosylatedmethylcytosine (5gmC) with
high specificity when compared to 5mC and C, and cleaves at
a narrow range of distances away from the recognized modified
cytosine. By mapping the cleaved ends, the exact 5hmC loca-
tions could be determined (Wang et al., 2011). Here we report
the genome-wide high-resolution hydroxymethylome of the
mouse E14 ESCs using AbaSI-coupled sequencing (Aba-seq).
RESULTS
Aba-seq and 5hmC Site Validation
DNA modification-dependent restriction endonuclease AbaSI
recognizes 5gmC with high specificity and generates double-568 Cell Reports 3, 567–576, February 21, 2013 ª2013 The Authorsstranded breaks at the 30 side of the binding sites (Wang et al.,
2011). AbaSI does not digest 5mC or C under the conditions
used (Figure S1A). The distances between the cleavage sites
and the modified cytosine are fixed within a narrow range, with
the majority 11–13 nucleotides away in the top strand and 9–
10 nucleotides away in the bottom strand (Wang et al., 2011).
The recognition and cleavage sites of AbaSI are shown in Fig-
ure 1A. AbaSI prefers sites with two cytosines positioned
symmetrically around the cleavage site: one is 5gmC and the
other can be modified or not (Figure 1A). AbaSI cleaves with
a lower efficiency when only one 5gmC is present (Wang et al.,
2011). Conversion of genomic 5hmC to 5gmC was completed
by using the T4 b-glucosyltransferase (Terragni et al., 2012) (Fig-
ure 1B). The AbaSI-digested DNA was first ligated to a bio-
tinylated DNA adaptor P1b containing 2-base randomized
30-overhang (Figure 1B). After fragmentation and end polishing,
bead-captured DNA was ligated to the second adaptor P2 (Fig-
ure 1B). Sequencing was initiated from the P1b end, and the
AbaSI cleavage sites were revealed after mapping the reads to
the reference genome. We determined that as low as 50 ng of
E14 genomic DNA is sufficient for successful library construction
(Figure S1B).
Putative 5hmC sites can be deduced by checking the pres-
ence of cytosine at expected distances (N13/N11,N12/N10,N11/
N9) from either side of the mapped cleavage sites (Figure 1A).
Based on the cytosine presence around the cleavage sites, we
categorized them into groups (Figure 1C), e.g., 1CG1CH signifies
one CG and one CH (H = A/C/T) at either side of the cleavage site
respectively; similarly, 1CG1XX signifies one CG on one side and
no cytosine on the other side. In groups with cytosines on both
sides, we prioritized the 5hmC assignment in the CG context
over the CH context. For example, 5hmC is assigned to the cyto-
sine in the CG context in the 1CG1CH group. For over 82%of the
cleavage sites, e.g., 1CG1CH, 1CG1XX, 1CH1XX, 5hmC can be
assigned to a single cytosine with high confidence. There is
assignment ambiguity to the exact cytosine base in categories
such as 2CGs or 2CHs and accounts for 13% of all identified
cleavage sites. These sites were included in our analysis as
one 5hmC site. A representative sequence logo is shown in Fig-
ure 1D for the 1CG1CH sites, demonstrating little bias exists
besides the recognized cytosines. There are only 5%of themap-
ped cleavage sites without suitable AbaSI recognition cytosines,
in contrast to an expected 25%by chance (Figure S1C).With two
technical replicates starting from AbaSI digestion, we obtained
242.0 (library R1) and 228.0 (library R2) million reads, of which
131.8 (54%) and 114.3 (50%) million reads were unambiguously
mapped to the reference genome. Within mapped reads, 124.7
and 107.8million 5hmC-induced reads were called, correspond-
ing to 17.6 and 15.2 million 5hmC sites respectively (see
Methods). There is a high degree of reproducibility between
the two replicates with 12,229,723 unique 5hmC sites in
common, which was used in the following analyses (Figure S1D).
Themean andmedian of the combined sequencing coverage for
these common 5hmC sites are 12.3X and 9X respectively (Fig-
ure S1E). In addition, within each library, sequencing coverage
for the common 5hmC sites is significantly higher than that for
the library-specific 5hmC sites (Figure S1E).
We further validated Aba-seq results using MspI and T4 b-glu-
cosyltransferase (Kinney et al., 2011). We quantified 5hmC
percentage at a number of CCGG sites with different read
coverage in the 1CG1CH and 1CG1XX categories. A strong posi-
tive correlation between the read coverage and 5hmC
percentage was observed (r = 0.73, Figure S1F). Background
levels of 5hmC at random, unreported CCGG sites are below
the detection limit (0.35% ± 0.56%). Levels of 5hmC for sites
with read coverage equal to 1 and 2 are significantly higher
than the background (mean = 2.2%, p value < 0.02, one-sided
Student’s t test), confirming the presence of 5hmC. The lowest
detectable 5hmC percentage in CCGG sites was around 2%,
giving an estimate on the sensitivity of Aba-seq. To validate
5hmC in the CH sites, we quantified AbaSI cleavage percentage
at these sites by individual quantitative PCR (qPCR), as shown in
Table S3. Similarly, all reported CH sites has significantly higher
5hmC readings than randomly chosen CH sites (p value < 1 3
109). Overall, our validation confirms Aba-seq resulted a high-
quality hydroxymethylome of the E14 cells. In addition, regional
5hmC levels, as reflected by the cumulative read numbers in
a genomic region, show strong correlation with the normalizedC5hmC site density (Figure S1G). Therefore, we will only show
results by using the 5hmC site density in subsequent analysis.
Comparison with the earlier hMeDIP data (Williams et al.,
2011) suggests that 95% of the enriched peaks contain at least
one Aba-seq 5hmC site. Importantly, the local 5hmC density of
those sites outside the hMeDIP peaks is much lower than that
of those inside (p value < 1 3 106, Figure S1H), which would
suggest that the 5hmC antibody used in hMeDIP may favor the
densely populated 5hmC regions. A recent study (TAB-seq)
also reported base-resolution hydroxymethylome in mouse
E14 cells with 2,057,636 5hmCs (Yu et al., 2012), about one sixth
of our results in size. A comparison between Aba-seq and TAB-
seq resulted in 1,246,351 common 5hmC sites (60.5% of TAB-
seq data). Among our validated 5hmCG sites, 12 (15%) were
reported in the TAB-seq data set. A notable difference between
the two methods is that TAB-seq may preferentially detect sites
with high 5hmC occupancy (Yu et al., 2012). However, compar-
ison in read numbers between Aba-seq-specific sites and the
Aba/TAB-seq common sites yielded no significant difference.
In addition, we compared our data and TAB-seq data with earlier
base-resolution data from the single-molecule sequencing
method (Song et al., 2011). Of the 744 hmCG sites reported by
that method (Song et al., 2012), 522 (70.2%) overlap with
Aba-seq and 123 (16.5%) overlap with TAB-seq. Further bio-
logical replicates and technical investigations are required to
interpret the discrepancies between the different methods.
Genomic View of the Hydroxymethylome in Mouse ESCs
In ESCs, a significant amount (20%–30%) of 5mC exists in CH
context, whereas this number reduces to negligible levels in
somatic cells (Lister et al., 2009, 2011; Stadler et al., 2011).
Based on our data, we estimate that 95.9% of all 5hmCs exists
in CG context, whereas 4.1% exist in CH context (1.4% CHG
and 2.7% CHH) (Figure 2A). These numbers differ from those re-
ported by TAB-seq, where close to 99% of 5hmCG were
observed (Yu et al., 2012). The average read number of the CH
group (10.0) is significantly smaller than that of the CG group
(12.4, p value < 13 106, two-sided Student’s t test), suggesting
lower 5hmC occupancy at the CH sites. Using 5hmCG sites with
significant read coverage by a bionomial distribution (p = 0.5), we
estimate that the percentage of the symmetrically hydroxyme-
thylated sites within the 5hmCG sites exceeds 90% (Figure S2A),
arguing against strand bias in hydroxylation of the fully methyl-
ated CG sites.
Examination of the 5hmC site density in chromosomes reveals
comparable levels across the autosomes, with a slightly increase
in chromosome 11 (Figure 2B). Sex chromosomes are depleted
in 5hmC, with little 5hmCs in the Y chromosome (Figure 2B).
Depletion of 5mC and 5hmC (Szulwach et al., 2011) in X chromo-
somes has been observed in neuronal tissues and stem cells.
Together these results suggest a different epigenetic regulation
mechanism between the autosomes and sex chromosomes. In
addition, we observed the highest 5hmC site density in the mito-
chondria genome in both CG and CH contexts (Figure 2B).
Considering that mitochondria genomes are present in multiple
copies in the cell, it remains inconclusive whether they are en-
riched in 5hmC. Nevertheless, insidemitochondria DNA, normal-
ized CH 5hmC site density is nearly as high as the normalized CGell Reports 3, 567–576, February 21, 2013 ª2013 The Authors 569
Figure 2. Genomic View of the Mouse ESC Hydroxymethylome
(A) Distribution of 5hmCG and 5hmCH sites in ESCs.
(B) 5hmCG (left y axis) and 5hmCH (right y axis) site densities by each chromosome.
(C) Distribution of 5hmC in different genomic elements.
(D) Strand-specific metaplot of normalized 5hmC and 5mC (Stadler et al., 2011) distribution near coding sequences.
See also Figure S2.5hmC site density, whereas it is less than 1% of the latter for all
other chromosomes (Figure 2B). A set of key DNA epigenetic
components, including DNMT1, TET enzymes, and their prod-
ucts 5mC and 5hmC, were reported in mitochondria (Shock
et al., 2011). Our results further suggest that the prevalent
pattern of hydroxymethylation, possibly methylation, in mito-
chondria genome might exist in an unbiased manner toward
CG or CH. Overall, our results suggest a different epigenome
in the mitochondria than that in the nucleus.
Most of the identified 5hmC sites reside in intergenic regions,
followed by introns (Figure 2C). Compared with a base-resolu-
tion methylome map in the mouse ESCs (Stadler et al., 2011)
(Figure S2B), 5hmCGs are slightly enriched in the intragenic
regions and depleted in the intergenic regions. This is consistent
with the previous findings using hMeDIP approaches (Ficz et al.,
2011). A gene-centric view of 5hmC as well as 5mC distribution
in both DNA strands is shown in Figure 2D. There is no noticeable570 Cell Reports 3, 567–576, February 21, 2013 ª2013 The Authorsdifference for the 5hmCG distribution between the sense and the
antisense strands (Figure 2D). We normalized the 5hmCG site
density by the 5mCG density, which accounts for the local
substrate concentration effect presented to the TET enzymes.
The normalized 5hmCG site density is reduced at the transcrip-
tion start sites (TSSs) and 50 UTR regions (Figure 2D), and
a similar trend is observed for the 5hmCH site (data not shown).
Interestingly, although the absolute 5hmCG and the 5mCG
densities are higher in exons than in introns, the normalized
5hmCG site density does not show difference between exons
and introns (Figure 2D). Overall, our results suggest that the
5hmC profile closely follows the 5mC distribution in the genic
regions (Lister et al., 2009).
Similar to 5mC, 5hmC is depleted in the CpG islands (CGIs) at
the genome scale (Figure 3A). Levels of 5hmC in CGIs, as esti-
mated by the cumulative reads, are inversely correlated with
the CpG density (Figure S2C), consistent with an earlier report
Figure 3. 5hmC Is Depleted in CGIs and Enriched in a Small Set of Repetitive Elements
(A) Upper panel: metaplot of CpG (black), normalized 5hmCG (red) and 5mCG (Stadler et al., 2011) (blue) distribution around the CGIs. Middle panel: heatmap
representation of 5hmC site density in all the genomic CGIs, ranked by the overall 5hmC density in each CGI.Wemanually separate the upper 5% into group I and
the lower 95% into group II. Lower panel: distribution of group I and group II CGIs in different genomic elements.
(B) Upper panel: metaplot of normalized 5hmCG and 5mCG (Stadler et al., 2011) around the LINE elements. Middle panel: heatmap representation of all the LINE
elements with 5hmC, ranked by the overall 5hmC content. Lower panel: averaged 5hmC density inside the selected LINE elements is significantly higher than that
in their flanking regions.
Error bars represent 1 SD. See also Figure S3.(Booth et al., 2012). We manually separated all CGIs into two
groups based on the overall ranked 5hmC density: group I (top
5%) and group II (lower 95%) (Figure 3A, middle panel). In group
I, even with the increased 5hmC density inside CGIs, there is no
significant enrichment compared with the flanking regions (data
not shown). Most of the group I CGIs appear in exonic regions,
whereas most of the group II CGIs appear in the TSS/promoter
regions (Figure 3A). The higher 5hmC density in exonic CGIs
may be due to their higher 5mC levels compared with the TSS/
promoter CGIs (Lister et al., 2009; Deaton and Bird, 2011).CAn observed enrichment of 5hmC in repetitive DNA, such as
LINE elements, has been previously reported (Ficz et al., 2011).
However, our results show that the genome-averaged 5hmC
density inside LINE is at the same level as their flanking regions
(Figure 3B). Detailed analysis separated all LINE elements into
three categories: (1) those that do not contain CpG sites inside
the elements (25%); (2) those that contain CpG sites but no
5hmCG sites (42%); and (3) those that contain both CpG sites
and 5hmCG sites (32%). Although category II can be regarded as
depleted of 5hmCG, there is moderate but significant 5hmCGell Reports 3, 567–576, February 21, 2013 ª2013 The Authors 571
Figure 4. 5hmC at the Protein-DNA Interacting Sites and Regions with Various Chromatin Modifications
Both absolute (top panel) and normalized (bottom panel) densities are displayed.
(A) 5hmC distribution around the ChIP-seq peaks of various DNA-interacting factors.
(B) Correlation between 5hmC and various chromatin marks. See also Figures S4 and S5.enrichment in category III (Figure 3B, middle and lower panel).
Similar patterns were observed for the SINE and LTR repetitive
elements (Figure S3). Overall, our results argue that there is
only a small fraction of repetitive elements showing 5hmC
enrichment in ESCs.
5hmC at the Protein-DNA Interaction Sites
5mC is generally depleted at the cis-elements to facilitate tran-
scription factor (TF) binding (Lister et al., 2009). By correlating
with a set of chromatin immunoprecipitation sequencing (ChIP-
seq) data, Figure 4A illustrates the representative 5hmC distribu-
tions around various protein-DNA interaction sites (Chen et al.,
2008).572 Cell Reports 3, 567–576, February 21, 2013 ª2013 The AuthorsThe first intriguing observation is a symmetrical, regularly
spaced oscillating distribution of 5hmCaround the CTCF binding
sites in both CG and CH context (Figure 4A). The center of the
CTCF binding sites are slightly CG-rich (Figure 4A, CpG line)
and depleted in 5mCG (Figure 4A, 5mCG/CG line), consistent
with the methylation sensitivity for the CTCF binding (Kurukuti
et al., 2006). Accordingly, 5hmCG and 5hmCH are depleted at
the center of the CTCF binding sites (Figure 4A). The distance
between the neighboring 5hmC peaks on either side of the
binding site is about 150 nucleotides (Figure 4A), reminiscent
of the unit length of the nucleosome-wound DNA. It was sug-
gested that CTCF binds to the linker DNA between the nucleo-
somes and the binding event leads to highly organized local
nucleosome array on both sides (Fu et al., 2008; Cuddapah et al.,
2009). The observed regularity of the 5hmC distribution is in line
with such local nucleosomal structure. This further suggests that
the local nucleosome environment may play an important role in
defining the 5hmC profile, possibly by affecting the 5mC acces-
sibility to the TET enzymes.
A second interesting observation is for the Nanog binding
sites, which show noticeable accumulation of 5hmCH at the
center, but not 5hmCG (Figure 4A). Similar patterns are also
observed for Sox2, Oct4, STAT3, Esrrb, and Tcfcp2I1 (Figures
4A and S4). Nanog/Oct4/Sox2 are known to co-occupy
a same set of loci in ESCs and their predicted binding motifs
do not contain CG dinucleotides (Chen et al., 2008). To investi-
gate whether non-CG 5-hydroxymethylation affects binding,
we then compared the binding affinity of Sox2 to the unmodified,
methylated, and hydroxymethylated sites (Figure S5). Our results
suggest that cytosinemodifications within the binding site do not
affect Sox2 binding. In addition, structural modeling reveals that
Sox2 binds DNA in the minor groove, whereas the five-position
modification of cytosine is located in the major groove and
thus not recognized (Figure S5). Further investigation is needed
to explain the non-CG accumulation of 5hmC around the binding
sites of these transcription factors.
For the other factors we studied, including c-myc, n-myc, Klf4,
E2f1, Zfx, and 5hmC, distribution was either slightly depleted or
relatively constant around the binding sites (Figures 4A and S4).
Binding sites of the histone acetyltransferase p300 showed
unique fluctuating 5hmC distributions (Figure 4A).
Correlation between 5hmC and Chromatin States
We next analyzed the 5hmC distribution around the ChIP-seq
peaks of various chromatin modification marks (Mikkelsen
et al., 2007), as shown in Figure 4B. Both 5mC and 5hmC are
depleted in regions marked with H3K4me3, an activation mark.
Furthermore, 5hmC is depleted in the RNA polII (Mikkelsen
et al., 2007) occupied regions (Figure S4), suggesting 5hmC is
generally excluded from active transcriptions. For regions
marked with H3K27me3, a repression mark, 5hmC does not
show obvious depletion or enrichment. Previous reports have
documented 5hmC enrichment in enhancer regions (Stroud
et al., 2011; Szulwach et al., 2011).We investigated a few histone
marks that are associated with enhancers. For the H3K27Ac
marked regions, which may act as active enhancers (Creyghton
et al., 2010), 5hmC is slightly depleted as well as 5mC. In
contrast, for the H3K4me1 marked regions, which may indicate
poised enhancers (Creyghton et al., 2010), both 5mC and
5hmC are enriched toward the center of the regions. Lastly,
both 5mC and 5hmC are enriched in the H4K20me3 marked
regions, which are associated with specific classes of repetitive
elements (Martens et al., 2005).
DISCUSSION
The epigenetic processes of 5hmC regulation remain elusive and
controversial after its rediscovery. Base-resolution genome-
wide hydroxymethylomes as well as methylomes provide the
first steps toward probing their biological relevance. Compared
with other bisulfite-conversion based methods, Aba-seq hasCseveral unique advantages: (1) simple library construction even
with low amount of input DNA (100 ng in our experiment); (2)
5hmC sites with low occupancy can be reliably detected; and
(3) data processing is more straightforward. Its potential limita-
tions, on the other hand, largely stem from the enzymatic prop-
erties of AbaSI (Wang et al., 2011). For example, target sites
are potentially cleaved with varying efficiency, with 5gmC at
both sides of the cleavage sites showing the highest efficiency
(Wang et al., 2011). However, this appears not a big concern
as such sites are only slightly overrepresented in our current
data set (Figure S1I). For a small portion of data (13% in our
data set), there is ambiguity in assigning 5hmC to the exact
base. Nevertheless, approximately 12.2M putative 5hmC sites
are detected in the mouse ESC genome and bioinformatic anal-
ysis has provided sufficiently fine details about the E14
hydroxymethylome.
Based on our results, we propose that factors affecting the
local 5mC accessibility to the TET enzymes play important roles
in the 5hmC deposition. These factors can include chromatin
compaction, nucleosome positioning, or TF binding. The most
striking example is the regularly oscillating 5hmC profile around
the CTCF-binding sites, suggesting 5hmC ‘‘writers’’ may be
sensitive to the nucleosomal environment. Similarly, the elevated
5hmC levels in the exonic regions are possibly due to a higher
concentration of more accessible 5mC sites. The 5hmC level
after normalization is actually comparable for the inter- and intra-
genic regions, arguing against specific enrichment of 5hmC in
either region. Depletion of 5hmCs is often observed when there
is depletion of 5mC, as seen in the TSS regions, binding sites of
RNA polII, and some TFs. For 5hmCs in other regions—in partic-
ular, poised enhancers marked by H3K4me1—the presence of
5hmC may indicate a transition or a poised state between meth-
ylation and demethylation. Finally, the unique mitochondrial hy-
droxymethylome and the locally increased CH hydroxymethyla-
tion at TF-binding sites such as NANOG and SOX2 await further
biological investigation.
EXPERIMENTAL PROCEDURES
Aba-seq Library Construction
The undifferentiated E14 cells was cultured as previously described (Kinney
et al., 2011). E14 cells were harvested and DNA extractedwith aQIAGENPure-
gene Core Kit (catalog no. 1042601) per manufacturer’s specifications. E14
genomic DNA was then treated with QIAGEN RNase A (catalog no. 19101).
Genomic DNA was glucosylated overnight at 37C by incubating 100 ng of
E14 genomic DNA with 200 mM UDP-glucose and 20 units of T4-b-glucosyl-
transferase (NEB: M0357S) in NEB buffer #4. Glucosylated genomic DNA
was subsequently purified by phenol-chloroform extraction and ethanol
precipitation. AbaSI digestion was done by incubating the glucosylated
genomic DNA with four units of AbaSI in NEB buffer #4 at room temperature
(25C) for 1 hr in a total reaction volume of 20 ml. The AbaSI digested DNA
was then purified by phenol-chloroform extraction and ethanol precipitation.
Biotinylated P1 adapters (Table S1) were ligated onto the AbaSI digested
DNA by incubating the digested DNA with 300 nM of P1 and 2 ml of T4 DNA
quick ligase (NEB: M2200) in the 1 3 quick ligation buffer in a total volume
of 42 ml at room for 30 min. Ligated DNA was then purified by running samples
on a 6% Tris-borate-EDTA (TBE) gel followed by gel excision of the DNA. Gel
extraction was done by crushing and soaking the isolated gel fragment (0.3M
NaOAC [pH 7.4], 2 mM EDTA) overnight at 37C followed by ethanol precipi-
tation of the DNA. Covaris s-series sonicator was used to shear the P1-ligated
genomic DNA to a range around 300 bp with the following settings: duty, 10;ell Reports 3, 567–576, February 21, 2013 ª2013 The Authors 573
intensity, 4; cycles per burst, 100; six cycles at 60 s. P1-ligated DNA was then
captured bymixing 50 ml of fragmented DNAwith 12.5 ml of DynabeadsMyOne
Streptavidin C1 beads (Life Technologies, catalog no. 650-01) according to the
manufacturer’s specifications. End repair was done by using the NEBNext End
Repair Module (NEB: E6050S) on the DNA-bound beads for 30 min at 20C.
The DNA-bound beads were then washed two times with a buffer containing
5 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, and 1 M NaCl; followed by wash
with H2O. A-tailing of the end-repaired DNA on beads was carried out by using
the NEBNext dA-Tailing Module (NEB: E6053S) for 30 min at 37C. The DNA-
bound beads were then washed as the previous step. P2 adapters (Table S1)
were ligated by incubating the DNA-bound beads with 250 nM of P2 and 2 ml of
T4 DNA quick ligase in the 13 quick ligation buffer at room temperature for
30 min. The DNA-bound beads were then washed as the previous steps.
Amplification of the DNA library was carried out by adding the entirety of
the DNA-bound beads to a reaction mixture containing 0.2 mM of each
dNTP, 13 Phusion HF Buffer, 300 nM forward primer (PCR_I), 300 nM reverse
primers (PCR_IIpe) (Table S1), and ten units of Phusion DNA polymerase (NEB:
M0531S). The following thermocycler conditions were utilized for amplifica-
tion: 30 s 98C, 16 cycles (10 s 98C, 15 s 70C, 15 s 72C), 10 min 72C,
and hold at 4C. The beads were then removed from the PCR and the library
was extracted by gel purification as described above.
Real-Time PCR Validation of Genomic 5hmC Sites
E14 genomic DNA used in this assay was same batch to that of the Aba-seq
library construction. Validation of genomic 5hmC at CCGG sites were carried
out by using the EpiMark 5hmC and 5mC Analysis Kit according to manufac-
turer’s specifications (NEB: E3317S). Real-time PCR of digested DNA was
done with iQ SYBR Green Supermix (BIO-RAD: 170-8882) per manufacturer’s
specifications.
Validation of genomic 5hmC at CH sites were done on AbaSI-digested glu-
cosylated E14 genomic DNA followed by real-time PCR. Real-time PCR of di-
gested DNA was done with iQ SYBR Green Supermix (BIO-RAD: 170-8882).
All real-time PCR primers and the method used to calculate 5hmC
percentage are listed in Table S2 for CCGG sites and Table S3 for CH sites.
Processing Aba-Seq Reads and Identification of 5hmC
All sequencing runs (two lanes) were done on the Illumina HiSeq platform with
read length of 50 bp. All the raw reads were mapped to the mouse reference
(UCSCmm9) using the Bowtie (Langmead et al., 2009) aligner with parameters
(-v 2 -m 1). We then interrogated neighboring sequences of the aligned AbaSI
cleavage sites in search of putative 5hmC sites at expected distance (–CN11-13
or +N9-11G). Copy number is defined as the total number of reads that resulted
from AbaSI digestion of a particular 5hmC site. Sequence logos were con-
structed using weblogo (Crooks et al., 2004). All scripts were written in
PERL and are available upon request.
Comparison to the Methylome in ESCs
CpGmethylome of mouse ESC by Bisulfite sequencing (BisSeq) was acquired
from NCBI Gene Expression Omnibus (GEO) database GSE30202 (Stadler
et al., 2011) and was used as a reference. 99% (11,066,961) of Aba-seq
5hmCG sites overlap with the 5mCG sites in this BisSeq data set. The
11,066,961 overlapped 5hmCG sites were used for the subsequent genomic
analyses of 5hmCG in this study.
Genome-wide 5hmC Profile in Different Genomic Regions
All genomic regions and their genomic coordinates were defined based on the
mm9 genome annotation tracks downloaded from UCSC Genome Browser
(Fujita et al., 2011) in February 2012. Different genomic elements were identi-
fied from the RefSeq genes track. Promoter is defined as 5 kb upstream of
nonredundant TSS. We define intergenic regions as 5 kb downstream of tran-
scription termination sites (TTS) that do not overlap with any known genic
regions.
To generate genome-wide metagene plots we divided 2 kb upstream region
of TSS, 50 UTR, exon, intron, 30 UTR, and 2 kb region downstream of each
nonredundant RefSeq gene into equal-sized bins respectively. For CGIs and
repetitive elements, we binned the same-length upstream and downstream
flanking regions into same number of intervals. CpG, 5mCG, 5hmCG, and574 Cell Reports 3, 567–576, February 21, 2013 ª2013 The Authors5hmCH sites were mapped to individual regions using BEDTOOL (Quinlan
and Hall, 2010). Site density was calculated as number of sites divided by
region length. 5hmCG density was also corrected by background CpG and
5mCG. Average densities were then computed for each bin position and
were used for metaplots or global trend plots.
Genomiccoordinatesof theCGIswereacquired fromthecpgIslandExt table in
UCSCdatabase. Depending on their locations,we classifiedCGIs into promoter
CGI, TSS CGI, exon CGI, intron CGI, 30 UTR CGI, and TTS CGI (a TSS or TTS
region is defined as 500 bp to +500 bp of a TTS or a TTS). Each type of CGIs
has at least 50% overlap with a region of that particular genomic feature.
Repetitive elements (LINE, SINE, and LTR) were retrieved from the Repeat-
Masker track in UCSC database.
Comparison to Other 5hmC Mapping Data Sets
We compared our Aba-seq data set to three different types of 5hmC mapping
data sets: hydroxymethylated DNA immunoprecipitation sequencing (Williams
et al., 2011); selective chemical labeling of 5hmC with single-molecule real-
time DNA sequencing (SMRT) (Song et al., 2012) and TAB-seq (Yu et al.,
2012).
(1) hMeDIP: We downloaded BED files containing genomic coordinates of
mapped sequencing reads from the NCBI GEO database (GSE24843).
5hmC-enriched regions were identified by the MACS (Zhang et al.,
2008) program using the following criteria: peak p value < 105 and
fold enrichment over immunoglobulin (Ig) G > 10.
(2) TAB-seq: Genomic coordinates of 2,057,636 reported high-confi-
dence TAB-seq hmC sites were kindly provided by the authors.
(3) SMRT: Genomic locations of 744 selected 5hmC in mouse ESCs from
initial shotgun SMRT DNA sequencing were obtained from Table S2 of
the published paper (Song et al., 2012).
All the above data sets were converted to BED format. Nonredundant
26-mer fragments flanking the AbaSI cleavage sites were used to compare
with the 5hmC-enriched regions derived from hMeDIP data. Comparison
between AbaSI-seq, TAB-seq, and SMRT were carried out at base resolution
by BEDTOOL.
Correlating 5hmC to ChIP-seq Data Sets
To create 5hmC profile at ChIP-seq peaks, we downloaded data sets from
NCBI.
(1) TET1 binding sites: BED files of mapped sequencing reads from a Tet1
ChIP-seq data set were downloaded from the GEO database
(GSE24843). TET1 binding regions were identified by the MACS
program using the following criteria: peak p value <108, fold enrich-
ment over IgG > 10.
(2) Histone modification marks: genome-wide maps of chromatin state
(H3K4me3, H3K27me3, H3K36me3, H4K20me3) were downloaded
from NCBI GEO database (GSE12241)(Mikkelsen et al., 2007). ChIP-
seq data sets of two enhancer histone mark H3K27ac and H3K4me1
were downloaded from NCBI GEO database (GSE24165) (Creyghton
et al., 2010). Genomic locations of mapped sequencing reads (mm8)
were remapped to mm9 via the LiftOver tool. Genomic intervals en-
riched with a specific chromatin mark were identified by the MACS
program using the following criteria: peak p value < 105, fold enrich-
ment over control H3 > 10.
(3) TFBS: Binding sites in mm8 of 13 TFs (Nanog, Oct4, STAT3, Smad1,
Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb, Tcfcp2l1, E2f1, and CTCF) and
two transcription regulators (p300 and Suz12) were downloaded
from the GEO database (GSE11431)(Chen et al., 2008). Genomic coor-
dinates were remapped to mm9 by the LiftOver tool.
(4) RNA polymerase II: locations of mapped sequencing reads of chro-
matin IP against RNA polymerase II were downloaded from NCBI
GEO database (GSE12241)(Mikkelsen et al., 2007). Genomic coordi-
nates were remapped to mm9 by the LiftOver tool. RNA polymerase
II binding intervals were identified by the MACS program using
the following criteria: peak p value < 105, fold enrichment over
control > 10.)
A region of 1 to +1 kbp around the peak summits or the binding centers
was selected and binned into 50 bp sliding windows at 25 bp steps. 5mCG,
5hmCG, 5hmCH, and CpG sites were aligned to individual bins and site
density profiles were normalized to the site density per 1 bp per bin. Global
trend plots were generated by calculating the average site density at each
bin position.
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